South Africa Drug Discovery Outsourcing Market Size & Outlook
The drug discovery outsourcing market in South Africa is expected to reach a projected revenue of US$ 225.8 million by 2033. A compound annual growth rate of 10.2% is expected of South Africa drug discovery outsourcing market from 2026 to 2033.
South Africa drug discovery outsourcing market highlights
The South Africa drug discovery outsourcing market generated a revenue of USD 105.0 million in 2025 and is expected to reach USD 225.8 million by 2033.
The South Africa market is expected to grow at a CAGR of 10.2% from 2026 to 2033.
In terms of segment, lead identification & candidate optimization was the largest revenue generating workflow in 2025.
Other Associated Workflow is the most lucrative workflow segment registering the fastest growth during the forecast period.
Drug discovery outsourcing market data book summary
Market revenue in 2025
USD 105.0 million
Market revenue in 2033
USD 225.8 million
Growth rate
10.2% (CAGR from 2026 to 2033)
Largest segment
Lead identification & candidate optimization
Fastest growing segment
Other Associated Workflow
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow
Key market players worldwide
Albany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex
Other key industry trends
In terms of revenue, South Africa accounted for 1.3% of the global drug discovery outsourcing market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Middle East & Africa, South Africa drug discovery outsourcing market is projected to lead the regional market in terms of revenue in 2033.
South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 225.8 million by 2033.
South Africa drug discovery outsourcing market is expected to witness growth in the coming years owing to the increasing demand for drug therapies and the presence of large un-met medical need in the region.
The Department of Science & Technology formed the Technology Innovation Agency through Technology Innovation Agency Act No. 26 in 2008, which supports the development of research in science councils, higher education institutions, & private research institutions and promotes technological innovation in the country.
Initiatives such as the African Network for Drugs and Diagnostics Innovation (ANDI), African Union (AU), and New Partnership for Africa's Development (NEPAD) try and fill research gaps in drug discovery & development and will further drive growth in this region.
South Africa Drug Discovery Outsourcing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Drug Discovery Outsourcing Market Outlook will help companies and investors design strategic landscapes.
Lead Identification & Candidate Optimization was the largest segment with a revenue share of 34.95% in 2025.
Horizon Databook has segmented the South Africa drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2021 to 2033.
South Africa drug discovery outsourcing market is expected to witness growth in the coming years owing to the increasing demand for drug therapies and the presence of large un-met medical need in the region.
The Department of Science & Technology formed the Technology Innovation Agency through Technology Innovation Agency Act No. 26 in 2008, which supports the development of research in science councils, higher education institutions, & private research institutions and promotes technological innovation in the country.
Initiatives such as the African Network for Drugs and Diagnostics Innovation (ANDI), African Union (AU), and New Partnership for Africa's Development (NEPAD) try and fill research gaps in drug discovery & development and will further drive growth in this region.
South Africa Drug Discovery Outsourcing Market Workflow Outlook (Revenue, USD Million , 2021-2033)
Target Identification & Screening
Target Validation & Functional Informatics
Lead Identification & Candidate Optimization
Preclinical Development
Other Associated Workflow
South Africa Drug Discovery Outsourcing Market Molecule Outlook (Revenue, USD Million , 2021-2033)
Small Molecules
Large Molecules
South Africa Drug Discovery Outsourcing Market Service Outlook (Revenue, USD Million , 2021-2033)
Chemistry Services
Biology Services
South Africa Drug Discovery Outsourcing Market Therapeutics Area Outlook (Revenue, USD Million , 2021-2033)
Respiratory system
Pain and Anesthesia
Oncology
Ophthalmology
Hematology
Cardiovascular
Endocrine
Gastrointestinal
Immunomodulation
Anti-infective
Central Nervous System
Dermatology
Genitourinary System
Others
South Africa Drug Discovery Outsourcing Market End Use Outlook (Revenue, USD Million , 2021-2033)
Pharmaceutical & Biotechnology companies
Academic Institutes
Reasons to subscribe to Drug Discovery Outsourcing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Drug Discovery Outsourcing Market Outlook databook
Our clientele includes a mix of Drug Discovery Outsourcing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa Drug Discovery Outsourcing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into South Africa Drug Discovery Outsourcing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
South Africa Drug Discovery Outsourcing Market, 2021-2033 (US$M)